Related Experiment Videos
[Cellular immunophenotypes in 97 adults with acute leukemia]
J Piedras1, X López-Karpovitch, M R Cárdenas
1Departamento de Hematología-Oncología, Laboratorio de Biología Celular, Instituto Nacional de la Nutrición Salvador Zubirán, Vasco de Quiroga, México, D.F.
Summary
Flow cytometry effectively diagnosed acute leukemia (AL) and identified acute mixed-lineage leukemia (AMLL). This immunophenotypic analysis confirmed the diverse nature of AL, aiding classification in challenging cases.
Area of Science:
- Hematology
- Immunology
- Flow Cytometry
- Leukemia Diagnosis
Context:
- Acute leukemia (AL) diagnosis often relies on cytomorphology and cytochemistry.
- Immunophenotyping by flow cytometry offers a more detailed analysis of cell surface antigens.
- Distinguishing between acute lymphoblastic leukemia (ALL) and acute myeloblastic leukemia (AML), especially mixed-lineage types, is critical for treatment.
Purpose:
- To analyze hematopoietic cell surface antigen reactivity in de novo acute leukemia (AL) using flow cytometry.
- To identify acute mixed-lineage leukemias (AMLL) based on established immunophenotypic criteria.
- To compare flow cytometry findings with cytomorphologic and cytochemical data for diagnostic accuracy.
Summary:
- Flow cytometry classified 12 previously unclassified AL cases.
- Immunophenotyping identified 54 ALL and 43 AML cases.
- AMLL was identified in 9% of ALL and 12% of AML cases, with CD34 expression in 90% of AMLL patients.
Impact:
- Flow cytometry provides crucial diagnostic information, especially in cytomorphologically ambiguous cases.
- The study confirms the heterogeneity of acute leukemia and the utility of immunophenotyping in defining subtypes.
- Accurate identification of AMLL through flow cytometry aids in precise diagnosis and potentially tailored therapeutic strategies.